The functional role of heteromers of G-protein-coupled receptors is a matter of debate. In the present study, we demonstrate that heteromerization of adenosine A1receptors (A1Rs) and A2Areceptors (A2ARs) allows adenosine to exert a fine-tuning modulation of glutamatergic neurotransmission. By means of coimmunoprecipitation, bioluminescence and time-resolved fluorescence resonance energy transfer techniques, we showed the existence of A1R–A2AR heteromers in the cell surface of cotransfected cells. Immunogold detection and coimmunoprecipitation experiments indicated that A1R and A2AR are colocalized in the same striatal glutamatergic nerve terminals. Radioligand-binding experiments in cotransfected cells and rat striatum showed that a main biochemical characteristic of the A1R–A2AR heteromer is the ability of A2AR activation to reduce the affinity of the A1R for agonists. This provides a switch mechanism by which low and high concentrations of adenosine inhibit and stimulate, respectively, glutamate release. Furthermore, it is also shown that A1R–A2AR heteromers constitute a unique target for caffeine and that chronic caffeine treatment leads to modifications in the function of the A1R–A2AR heteromer that could underlie the strong tolerance to the psychomotor effects of caffeine.
Antagonistic and reciprocal interactions are known to exist between adenosine and dopamine receptors in the striatum. In the present study, double immunofluorescence experiments with confocal laser microscopy showed a high degree of colocalization of adenosine A2A receptors (A2AR) and dopamine D2 receptors (D2R) in cell membranes of SH-SY5Y human neuroblastoma cells stably transfected with human D2R and in cultured striatal cells. A2AR/D2R heteromeric complexes were demonstrated in coimmunoprecipitation experiments in membrane preparations from D2R-transfected SH-SY5Y cells and from mouse fibroblast Ltk− cells stably transfected with human D2R (long form) and transiently cotransfected with the A2AR double-tagged with hemagglutinin. Long term exposure to A2AR and D2R agonists in D2R-cotransfected SH-SY5Y cells resulted in coaggregation, cointernalization and codesensitization of A2AR and D2R. These results give a molecular basis for adenosine-dopamine antagonism at the membrane level and have implications for treatment of Parkinson's disease and schizophrenia, in which D2R are involved.
11 July 2000 in Proceedings of the National Academy of Sciences
The possible molecular basis for the previously described antagonistic interactions between adenosine A 1 receptors (A 1 R) and dopamine D 1 receptors (D 1 R) in the brain have been studied in mouse fibroblast Ltk − cells cotransfected with human A 1 R and D 1 R cDNAs or with human A 1 R and dopamine D 2 receptor (long-form) (D 2 R) cDNAs and in cortical neurons in culture. A 1 R and D 1 R, but not A 1 R and D 2 R, were found to coimmunoprecipitate in cotransfected fibroblasts. This selective A 1 R/D 1 R heteromerization disappeared after pretreatment with the D 1 R agonist, but not after combined pretreatment with D 1 R and A 1 R agonists. A high degree of A 1 R and D 1 R colocalization, demonstrated in double immunofluorescence experiments with confocal laser microscopy, was found in both cotransfected fibroblast cells and cortical neurons in culture. On the other hand, a low degree of A 1 R and D 2 R colocalization was observed in cotransfected fibroblasts. Pretreatment with the A 1 R agonist caused coclustering (coaggregation) of A 1 R and D 1 R, which was blocked by combined pretreatment with the D 1 R and A 1 R agonists in both fibroblast cells and in cortical neurons in culture. Combined pretreatment with D 1 R and A 1 R agonists, but not with either one alone, substantially reduced the D 1 R agonist-induced accumulation of cAMP. The A 1 R/D 1 R heteromerization may be one molecular basis for the demonstrated antagonistic modulation of A 1 R of D 1 R receptor signaling in the brain. The persistence of A 1 R/D 1 R heteromerization seems to be essential for the blockade of A 1 R agonist-induced A 1 R/D 1 R coclustering and for the desensitization of the D 1 R agonist-induced cAMP accumulation seen on combined pretreatment with D 1 R and A 1 R agonists, which indicates a potential role of A 1 R/D 1 R heteromers also in desensitization mechanisms and receptor trafficking.
Exploring the role of cannabinoid CB(2) receptors in the brain, we present evidence of CB(2) receptor molecular and functional interaction with cannabinoid CB(1) receptors. Using biophysical and biochemical approaches, we discovered that CB(2) receptors can form heteromers with CB(1) receptors in transfected neuronal cells and in rat brain pineal gland, nucleus accumbens, and globus pallidus. Within CB(1)-CB(2) receptor heteromers expressed in a neuronal cell model, agonist co-activation of CB(1) and CB(2) receptors resulted in a negative cross-talk in Akt phosphorylation and neurite outgrowth. Moreover, one specific characteristic of CB(1)-CB(2) receptor heteromers consists of both the ability of CB(1) receptor antagonists to block the effect of CB(2) receptor agonists and, conversely, the ability of CB(2) receptor antagonists to block the effect of CB(1) receptor agonists, showing a bidirectional cross-antagonism phenomenon. Taken together, these data illuminate the mechanism by which CB(2) receptors can negatively modulate CB(1) receptor function.